MaxiVAX
MaxiVAX is a Swiss clinical-stage biotechnology company.
Total raised
€4.3M
€4,300,000
Funding rounds
1
Investors
0
distinct backers
Active since
2019-09
latest 2019-09
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood19
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series B | €4.3M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy